Logo Image
News
Academy
Publications
All PublicationseBooks
Media
Editorial PodcastsEditorial VideosPeer ExchangePractice AcademyShortsSponsored PodcastsSponsored Videos
More
Conferences
Conference CoverageConference Listing
Columns
All ColumnsA Closing ThoughtClinical Trial InsightsView from BrusselsView from Washington
Resources
AdvertiseBlogsEventsFront & CenterPartner PerspectivesWhite Papers
Events
Webcasts
Event Calendar

Subscribe

  • News
  • Academy
  • Publications
  • Media
  • Conferences
  • Columns
  • Resources
  • Events
  • Subscribe
  • Event Calendar
  • Clinical Operations & Strategy
    • Decentralized Clinical Trials
    • Trial Design
    • Investigative Sites
    • CRO/Sponsor
    • Risk-Based Monitoring
    • Protocol Design
    • Clinical Trial Supply Chain
    • Study Start-Up
    • Early Phase Development
  • DEI
    • Industry Initiatives
    • Diversity Action Plans
    • Recruitment
  • Data Management
    • Analytics
    • Electronic Data Capture
    • Real World Evidence
    • Metrics & Benchmarks
  • Patient Participation
    • Integrated Research
    • CRAACO
    • Enrollment
  • Regulatory
    • Institutional Review Board & Ethics Committee
    • FDA
    • EMA
  • Technology
    • Artificial Intelligence/Machine Learning
    • eClinical
    • mHealth
Spotlight -
Conference Coverage|
Peer Exchange|
DE&I|
Editorial Videos|
Clinical Operations & Strategy|
Patient Participation
Advertisement

Ashley Moultrie, CCRP

Advertisement

Articles by Ashley Moultrie, CCRP

Image credit: Pixel-Shot | stock.adobe.com

The Consequences of Underrepresentation in Clinical Trial Design

ByAshley Moultrie, CCRP
April 23rd 2024

A representative sample patient population that accurately reflects the overall population is vital to establish the safety and efficacy of a drug.

Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on Applied Clinical Trials Online

    1

    IgniteData and RealTime Partner to Streamline Clinical Data Transfer From eSource to Sponsor Systems

    2

    The Biggest Remaining Barriers to High-Quality RWE Across Oncology Data Platforms

    3

    ACT Brief: Design Drivers of Trial Representation, eSource-to-EDC Data Automation, and Roche's ALK7 Obesity License

    4

    Flexible Clinical Operations and Site Management Across a Diversified Biotech Portfolio: An Application of Quality by Design and Risk-Based Oversight

    5

    Beyond Outreach: Structural Drivers of Representation in Clinical Trials

    • About
    • Advertise
    • Contact Us
    • Editorial Contacts
    • Do Not Sell My Personal Information
    • Privacy Policy
    • Terms and Conditions
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    • Applied Clinical Trials
    • BioPharm International
    • Cannabis Science and Technology
    • Chromatography Online
    • Nutritional Outlook
    • Pharmaceutical Commerce
    • Pharmaceutical Executive
    • Pharm Tech
    • Spectroscopy Online
    • Turbo Machinery Magazine
    IS1
    Brand Logo

    © 2026 MJH Life Sciences®

    All rights reserved.

    Home
    About Us
    News
    Contact Us